Jeffrey Siewerdsen

Turner Imaging Systems Announces Collaboration with Massachusetts General Hospital

Retrieved on: 
Tuesday, January 12, 2021

Turner Imaging Systems , developers of the revolutionary Smart-C X-ray imaging system, has entered into a Sponsored Research Project with Massachusetts General Hospital to investigate the use of the Smart-C for weight-bearing radiographs of the foot and ankle.

Key Points: 
  • Turner Imaging Systems , developers of the revolutionary Smart-C X-ray imaging system, has entered into a Sponsored Research Project with Massachusetts General Hospital to investigate the use of the Smart-C for weight-bearing radiographs of the foot and ankle.
  • By conducting a clinical trial, FARIL aims to evaluate the use of the Turner Imaging Systems Smart-C for weight-bearing radiographs.
  • Massachusetts General Hospital, a global pioneer in medical and diagnostic technology, is a leader in the healthcare industry.
  • Turner Imaging Systems, based in Orem, Utah, received FDA 510(k) clearance of the Smart-C mini C-arm portable fluoroscopy X-ray imaging device in September of 2019.

3D CT Imaging Expert Joins Izotropic Advisory

Retrieved on: 
Thursday, January 7, 2021

His research is focused on new medical imaging technologies and algorithms, including CT and cone-beam CT (CBCT), image reconstruction and registration, and the physics of image quality.

Key Points: 
  • His research is focused on new medical imaging technologies and algorithms, including CT and cone-beam CT (CBCT), image reconstruction and registration, and the physics of image quality.
  • Dr. Siewerdsen's contributions include the development of new 3D imaging systems for image-guided radiation therapy, image-guided surgery, and point-of-care diagnostic imaging in orthopaedics and neuro-critical care.
  • Underlying such systems are advanced algorithms for high-quality 3D image reconstruction and registration as well as mathematical models of 3D image quality to optimize the design of new imaging systems for particular imaging tasks.
  • Dr. Siewerdsen's appointment to the Scientific Advisory Board expands the Company's expertise in developing the Breast CT imaging platform for new and complementary products.

Fujifilm Enters U.S. Surgical C-Arm and Radiographic Fluoroscopy Markets

Retrieved on: 
Thursday, November 19, 2020

LEXINGTON, Mass., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc ., a leading provider of diagnostic imaging and medical informatics solutions, has entered the surgical and fluoroscopy markets with two new systems: the Persona C Surgical C-Arm and Persona RF PREMIUM System.

Key Points: 
  • LEXINGTON, Mass., Nov. 19, 2020 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc ., a leading provider of diagnostic imaging and medical informatics solutions, has entered the surgical and fluoroscopy markets with two new systems: the Persona C Surgical C-Arm and Persona RF PREMIUM System.
  • Persona C surgical c-arm is an advanced imaging solution engineered for fast, precise positioning and advanced image quality across a broad range of diagnostic imaging and minimally invasive surgical procedures.
  • It will be available with 21x21cm or 30x30cm amorphous Silicon (aSi) flat panel detector options for ultra-low dose fluoroscopy and vascular imaging.
  • Individuals interested in learning more about the newest c-arm and radiographic fluoroscopy systems can book a virtual demo with Fujifilm by visiting: https://www.infowebpage.com/FujiRSNA2020/
    FUJIFILM Medical Systems U.S.A., Inc .

The global CBCT systems market at a CAGR of over 10% during the forecast period

Retrieved on: 
Thursday, December 26, 2019

NEW YORK, Dec. 26, 2019 /PRNewswire/ -- Global Cone Beam Computed Tomography (CBCT) Systems Market: About this market

Key Points: 
  • NEW YORK, Dec. 26, 2019 /PRNewswire/ -- Global Cone Beam Computed Tomography (CBCT) Systems Market: About this market
    This CBCT systems market analysis considers sales from both stand-alone CBCT systems and mobile CBCT systems.
  • In 2019, the stand-alone CBCT systems segment had a significant market share, and this trend is expected to continue over the forecast period.
  • Also, our global CBCT systems market report looks at factors such as the prevalence of dental, orthopedic and cancer conditions, rising number of new product launches, and growing adoption of mobile CBCT systems.
  • However, high costs associated with CBCT imaging, frequent product recalls, and stringent regulations associated with CBCT systems may hamper the growth of the CBCT systems industry over the forecast period.

Global Cone Beam Computed Tomography (CBCT) Systems Market 2020-2024 | Evolving Opportunities with CurveBeam LLC and Genoray Co. Ltd. | Technavio

Retrieved on: 
Tuesday, December 3, 2019

Technavio has been monitoring the global cone beam computed tomography (CBCT) systems market and the market is poised to grow by USD 489.15 million during 2020-2024 at a CAGR of over 10% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global cone beam computed tomography (CBCT) systems market and the market is poised to grow by USD 489.15 million during 2020-2024 at a CAGR of over 10% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20191203005418/en/
    Technavio has announced its latest market research report titled global cone beam computed tomography (CBCT) systems market 2020-2024.
  • (Graphic: Business Wire)
    Read the 143-page research report with TOC on "Cone Beam Computed Tomography (CBCT) Systems Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Stand-alone CBCT systems and Mobile CBCT systems), and Segment Forecasts, 2020-2024".
  • In addition, the integration of software tools in CBCT systems is anticipated to further boost the growth of the cone beam computed tomography (CBCT) systems market.

Mevion’s CBCT Imaging Solution from medPhoton Receives FDA Clearance

Retrieved on: 
Thursday, September 5, 2019

Mevion Medical Systems is pleased to announce its strategic partner, medPhoton GmbH, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ceiling-mounted ImagingRing, an innovative in-room cone-beam computed tomography (CBCT) imaging system.

Key Points: 
  • Mevion Medical Systems is pleased to announce its strategic partner, medPhoton GmbH, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ceiling-mounted ImagingRing, an innovative in-room cone-beam computed tomography (CBCT) imaging system.
  • View the full release here: https://www.businesswire.com/news/home/20190905005077/en/
    The MEVION S250i Proton Therapy System with the ImagingRing CBCT at Maastro Proton Therapy in the Netherlands.
  • We are excited to receive FDA clearance for the ImagingRing, said Heinz Deutschmann, chief executive officer and founder of medPhoton .
  • We congratulate medPhoton on the 510(k) clearance of the ImagingRing, said Tina Yu, chief executive officer of Mevion Medical Systems.

Global $3.96 Billion Flat Panel Detector (FPD)-based X-ray for Cone Beam Computed Tomography (CBCT) Market to 2025

Retrieved on: 
Wednesday, November 21, 2018

The "Flat Panel Detector (FPD)-based X-ray for Cone Beam Computed Tomography (CBCT) Market Size, Share & Trends Analysis Report By Product (Sitting, Standing, Lying Down), By Application (Dental, ENT, Orthopedics), By End Use, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Flat Panel Detector (FPD)-based X-ray for Cone Beam Computed Tomography (CBCT) Market Size, Share & Trends Analysis Report By Product (Sitting, Standing, Lying Down), By Application (Dental, ENT, Orthopedics), By End Use, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
  • The global flat panel detector (FPD) based x-ray for cone beam computed tomography (CBCT) market size is likely to reach USD 3.96 billion by 2025, progressing at a CAGR of 8.07% during the forecast period.
  • The FPD-based X-ray for CBCT market is consolidated, marked by presence of a few well-established players that account for the largest cumulative revenue share.
  • Further key findings from the report suggest:
    Orthopedics dominated the FPD-based X-ray CBCT market in 2017, owing to higher adoption of the technology for orthopedic imaging.

The EMEA 3D cone beam computed tomography systems market is projected to reach USD 300.4 million by 2023 from estimated USD 194.3 million in 2018, at a CAGR of 9.0%

Retrieved on: 
Thursday, June 7, 2018

The EMEA 3D cone beam computed tomography systems market is projected to reach USD 300.4 million by 2023 from estimated USD 194.3 million in 2018, at a CAGR of 9.0%.

Key Points: 
  • The EMEA 3D cone beam computed tomography systems market is projected to reach USD 300.4 million by 2023 from estimated USD 194.3 million in 2018, at a CAGR of 9.0%.
  • The growing prevalence of dental disorders is also expected to boost the demand for advanced dental imaging systems such as 3D CBCT.
  • This report provides insights into the following pointers:
    Market Penetration: Comprehensive information on product portfolios offered by the top players in the EMEA 3D cone beam computed tomography systems market.
  • The report analyzes the EMEA 3D cone beam computed tomography systems market by application, end user, and region.